Skip to search formSkip to main contentSkip to account menu

MammaPrint

An in vitro molecular diagnostic test that uses gene expression profiling to analyze gene activity within a breast cancer tumor sample. It looks at… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making.
2017
2017
[70-Gene signature as an aid to treatment decisions in early-stage breast cancer].
OBJECTIVE The 70-gene signature test (MammaPrint) has been shown to improve prediction of clinical outcome in women with early… 
Review
2015
Review
2015
Gene expression-based prognostic and predictive tools in breast cancer
Genomic assays measuring the expression of multiple genes have made their way into clinical practice and their utilization is now… 
2012
2012
Data Graphs for Linking Clinical Phenotype and Molecular Feature Space
Omics profiling in translational clinical research has provided detailed molecular characterization of disease phenotypes… 
2012
2012
Interpreting Personal Transcriptomes: Personalized Mechanism-Scale Profiling of RNA-seq Data
Despite thousands of reported studies unveiling gene-level signatures for complex diseases, few of these techniques work at the… 
2012
2012
Abstract P6-07-03: Risk classification of Early Stage Breast Cancer as Assessed by MammaPrint and OncotypeDX Genomic Assays:
Background: The 21-gene Oncotype DX® Recurrence Score® assay has been validated for prediction of 10-year risk of distant… 
Review
2011
Review
2011
Molecular Predictors of Response to Therapy for Breast Cancer
For several decades, measurements from tumor tissue biomarkers have been used to identify subsets of breast cancer patients that… 
2010
2010
Tumour tissue: who is in control?
Review
2008
Review
2008
Critical review of microarray-based prognostic tests and trials in breast cancer
Purpose of review We critically review the methods used in microarray profiling, the reliability of published genomic signatures… 
Review
2008
Review
2008
Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.
PURPOSE The clinical and economic data for the two currently available gene-expression assays are reviewed. SUMMARY Two gene… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)